We have also shown that while CSPG4 expression in melanoma might be linked to pro-survival, a drop in expression in HNSCCs linked to the change in a tumour from a pre-metastatic to a metastatic clinical stage was also observed (Figure 5). This evidence concerns the gene CSPG4 and neoplasm.